Key result
Genetic testing identifies a pathogenic KCNH2 variant in nonagenarian torsades managed with leadless pacing.
Why the study?
Congenital long QT syndrome is typically diagnosed in youth, and its recognition in advanced age is rare and may be delayed when arrhythmic syncope mimics epilepsy.
Case Report (n=1)
Persistent QT prolongation after reversible factors are corrected should prompt consideration of congenital long QT syndrome regardless of advanced age.
Extends congenital LQTS2 phenotypic spectrum to nonagenarians; hypothesis-generating and should not yet change screening practices.
BACKGROUND: Congenital long QT syndrome (LQTS) is typically diagnosed in youth. Recognition in advanced age is rare and may be delayed when arrhythmic syncope mimics epilepsy. CASE SUMMARY: A 93-year-old man with recurrent convulsive syncope presented with marked QT prolongation, notched T waves, and pause-dependent torsades de pointes/pulseless ventricular tachycardia initiated by premature ventricular contractions. Four years earlier, torsades de pointes had been attributed to mild hypokalemia and famotidine, although QTc interval remained prolonged after correction. Genetic testing identified a pathogenic KCNH2 frameshift variant, confirming congenital LQTS type 2. Advanced age, chronic kidney disease, and bradyarrhythmia likely reduced repolarization reserve. An implantable cardioverter-defibrillator was discussed but not pursued after a goals-of-care discussion; leadless pacing was used to reduce pauses, and beta-blocker therapy continued. DISCUSSION: Congenital LQTS may remain occult into advanced age when acquired factors reduce repolarization reserve. TAKE-HOME MESSAGE: Persistent QT prolongation after reversible factors are corrected should prompt consideration of congenital LQTS regardless of age.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2026) conducted a case report in Congenital long QT syndrome type 2 (n=1). Leadless pacing and beta-blocker therapy was evaluated. Genetic testing identified a pathogenic KCNH2 frameshift variant in a 93-year-old man with torsades de pointes, managed with leadless pacing and beta-blocker therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: